Median time to minimal symptoms was @ minutes ( @-@ ) in rhC@INH-treated patients vs @ minutes ( @-@ ,@ ) in placebo-treated patients based on the TEQ ( P = @ ) and @ minutes ( @-@ ) vs @ minutes ( @ , not estimable ; P = @ ) , based on an overall VAS less than @ mm .